UnknownPhase 2NCT03542851
A Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia
Studying Idiopathic hypersomnia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Balance Therapeutics
- Principal Investigator
- Morgan LamChief Operating Officer
- Intervention
- Pentetrazol (PTZ)(drug)
- Enrollment
- 80 target
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2018 – 2020
Study locations (30)
- Sleep Disorders Center of Alabama, Birmingham, Alabama, United States
- Mayo Clinic Hospital, Scottsdale, Arizona, United States
- SDS Clinical Trials, Orange, California, United States
- Pacific Research Network, San Diego, California, United States
- Sleep Medicine Specialists of California, San Ramon, California, United States
- Santa Monica Clinical Trials, Santa Monica, California, United States
- REM Sleep Medicine, Boulder, Colorado, United States
- PAB Clinical Research, Brandon, Florida, United States
- Sleep Medicine Specialists of South Florida, Miami, Florida, United States
- Florida Premier Research Institute, Winter Park, Florida, United States
- NeuroTrials Research Inc., Atlanta, Georgia, United States
- Sleep Practicioners, Macon, Georgia, United States
- Northshore Sleep Medicine, Northbrook, Illinois, United States
- Fort Wayne Neurology, Fort Wayne, Indiana, United States
- Rowe Neurology Institute, Lenexa, Kansas, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03542851 on ClinicalTrials.govOther trials for Idiopathic hypersomnia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07500090A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)Harmony Biosciences Management, Inc.
- RECRUITINGNCT06732284Study of Sleep Inertia in Major Depressive Disorder by the Psychomotor Vigilance TaskCentre Hospitalier Universitaire de Nīmes
- RECRUITINGPHASE2NCT07096674A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic HypersomniaCentessa Pharmaceuticals (UK) Limited
- RECRUITINGNANCT07006233A Novel Approach to Manage Symptoms of Narcolepsy and Idiopathic HypersomniaUniversity of Sydney
- RECRUITINGPHASE2NCT06843590A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic HypersomniaAlkermes, Inc.
- RECRUITINGPHASE2NCT06812078A Study of TAK-360 in Adults With Idiopathic HypersomniaTakeda
- RECRUITINGPHASE2, PHASE3NCT06767683A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic HypersomniaAlkermes, Inc.
- RECRUITINGPHASE2NCT06752668A Study of ORX750 in Participants With Narcolepsy and Idiopathic HypersomniaCentessa Pharmaceuticals (UK) Limited